Literature DB >> 10888001

Activity of closantel against adult triclabendazole-resistant Fasciola hepatica.

G C Coles1, A C Rhodes, K A Stafford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10888001     DOI： 10.1136/vr.146.17.504-a

Source DB:  PubMed          Journal:  Vet Rec        ISSN： 0042-4900            Impact factor:   2.695


× No keyword cloud information.
  12 in total

1.  Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.

Authors:  M McConville; G P Brennan; M McCoy; R Castillo; A Hernandez-Campos; F Ibarra; I Fairweather
Journal:  Parasitol Res       Date:  2006-10-03       Impact factor: 2.289

2.  Evidence for multiple mitochondrial lineages of Fasciola hepatica (liver fluke) within infrapopulations from cattle and sheep.

Authors:  S M Walker; P A Prodöhl; H L Fletcher; R E B Hanna; V Kantzoura; E M Hoey; A Trudgett
Journal:  Parasitol Res       Date:  2007-01-11       Impact factor: 2.289

3.  A deep exploration of the transcriptome and "excretory/secretory" proteome of adult Fascioloides magna.

Authors:  Cinzia Cantacessi; Jason Mulvenna; Neil D Young; Martin Kasny; Petr Horak; Ammar Aziz; Andreas Hofmann; Alex Loukas; Robin B Gasser
Journal:  Mol Cell Proteomics       Date:  2012-08-16       Impact factor: 5.911

4.  Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro.

Authors:  S M Walker; B McKinstry; J C Boray; G P Brennan; A Trudgett; E M Hoey; H Fletcher; I Fairweather
Journal:  Parasitol Res       Date:  2004-10-28       Impact factor: 2.289

5.  The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

Authors:  Mark W Robinson; Jill Lawson; Alan Trudgett; Elizabeth M Hoey; Ian Fairweather
Journal:  Parasitol Res       Date:  2003-12-03       Impact factor: 2.289

6.  The effect of the microtubule inhibitor tubulozole-C on the tegument of triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

Authors:  Mark W Robinson; Alan Trudgett; Elizabeth M Hoey; Ian Fairweather
Journal:  Parasitol Res       Date:  2003-08-09       Impact factor: 2.289

Review 7.  Zoonotic helminth infections with particular emphasis on fasciolosis and other trematodiases.

Authors:  Mark W Robinson; John P Dalton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-09-27       Impact factor: 6.237

8.  Morphological response of triclabendazole-susceptible and triclabendazole-resistant isolates of Fasciola hepatica to treatment in vitro with nitroxynil (Trodax).

Authors:  B McKinstry; L Halferty; G P Brennan; I Fairweather
Journal:  Parasitol Res       Date:  2008-11-18       Impact factor: 2.289

9.  First report of closantel treatment failure against Fasciola hepatica in cattle.

Authors:  Adam Novobilský; Johan Höglund
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-08-28       Impact factor: 4.077

10.  Assessment of flukicide efficacy against Fasciola hepatica in sheep in Sweden in the absence of a standardised test.

Authors:  Adam Novobilský; Natalia Amaya Solis; Moa Skarin; Johan Höglund
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-06-26       Impact factor: 4.077
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.